Viral hepatitis: Croatian consensus statement;Virusni hepatitis: Hrvatska konsenzus konferencija

Acta Medica Croatica

Volumn 59, Issue 5, 2005, Pages 359-375

  Vucelić, Boris ^a   Hrstić, Irena ^b   Begovac, Josip ^b   Bradarić, Nikola ^b   Burek, Vitomir ^b   Čolić Cvrlje, Vesna ^b   Duvnjak, Marko ^b   Kekez, Alemka Jaklin ^b   Kes, Petar ^b   Lesnikar, Vladimira ^b   Miše, Stjepan ^b   Morovic, Miro ^b   Ostojic, Ranko ^b   Pavic, Ivica ^b   Štimac, Davor ^b   Včev, Aleksandar ^b   Vince, Adriana ^b  

^a KBC Zagreb   (Croatia)

^b NONE

Author keywords

Consensus conference; Viral hepatitis

Indexed keywords

ADEFOVIR DIPIVOXIL; ALPHA INTERFERON; ALPHA2A INTERFERON; HEPATITIS B ANTIBODY; LAMIVUDINE; PEGINTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; CONSENSUS; DELTA AGENT HEPATITIS; DIALYSIS; GASTROENTEROLOGY; HEALTH INSURANCE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPROPHYLAXIS; LIVER TRANSPLANTATION; NEPHROLOGY; NONHUMAN; PREVALENCE; PROPHYLAXIS; VIRUS HEPATITIS;

CONSENSUS DEVELOPMENT CONFERENCES; CROATIA; HEPATITIS, VIRAL, HUMAN; HUMANS;

EID: 29144440312     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Lok ASF, McMahon BJ. AASLD practice guideline: Chronic Hepatitis B: Update of Recommendations Hepatology 2004; 39: 1-5.
2. Lok ASF, McMahon BJ. Hepatitis B: Update of recommendations. Hepatology 2004; 39: 857-61.
3. Keeffe EM, Dietrich DT, Han S-HB i sur. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. Clin Gastroenterol Hepatol 2004; 2: 87-106.
4. The EASL Jury. EASL international consensus conference on hepatitis B. Consensus statement (Short version). J Hepatol 2003; 38: 533-540.
5. The EASL Jury. EASL Consensus Conference on Hepatitis B. Consensus statement (Long version). J Hepatol 2003; 39(Suppl 1): 3-25.
6. Liaw YF, Leung N, Guan R, Lau GKK, Merican I. Asian-Pacific consensus statement on the management of chronic hepatitis B: An update. J Gastroenterol Hepatol 2003; 18: 239-245.
7. Consensus conference - Vaccination against the hepatitis B virus, Paris, France, 10-11 September 2003.
8. Lok ASF, Heathcote EJ, Hoofnagle JH. Management of Hepatitis B 2000, Summary of Workshop. Gastroenterology 2001; 108: 925-6.
9. Consensus statement on the prevention and management of hepatitis B and hepatitis C in the Asia-Pacific region. J Gastroenterol Hepatol 2000; 15: 825-41.
10. Han SHB, Ofman J, Holt C i sur. A efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy. Liver Transpl 2000; 6: 741-8.
11. Jara P, Bortolotti F. Interferon alpha treatment of chronic hepatitis B in childhood: a consensus advice based on experience in European children. J Pediatr Gastroenterol Nutr 1999; 29: 163-70.
12. Strader DB, Wright T, Thomas DL, Seeff LB. AASLD Practice Guideline. Diagnosis, Management and Treatment of Hepatitis C. J Hepatol 2004; 39: 1147-71.
13. Management of chronic viral hepatitis: a Canadian consensus conference 2004. Can J Gastroenterol 2004; 18: 715-728.
14. Soriano V, Miro JM, Garcia-Samanigo J i sur. Consensus conference on chronic hepatitis and HIV infection: updated Spanish recommendations. J Virol Hepat 2004; 11: 2-17.
15. Dhumeaux D, Marcellin P, Lerebours E. Treatment of hepatitis C. The 2002 French Consensus. Gut 2003; 52: 1784-7.
16. Management of hepatitis C: 2002. NIH Consensus State Statements. 2002; 19: 1-46.
17. NIH Consensus Development Conference Statement: Management of hepatitis C: 2002. Hepatology 2002; 36(Suppl 1): 3-20.
18. National Institutes of Health Consensus Development Conference Statement. Management of hepatitis C 2002. Gastroenterology 2002; 123: 2082-99.
19. Consensus Conference: Treatment of hepatitis C. Agence Nationale d'Accreditation et d'Evaluation en Sante (ANAES). Paris, France, 2002. www.anaes.fr
20. Consensus conference: Treatment of hepatitis C. Paris, France, 27-28 February 2002.
21. EASL International Consensus Conference on Hepatitis C. Consensus Statement. J Hepatol 1999; 30: 956-61.
22. National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology 1997; 26 /suppl 1/; 2-105.
23. Soriano V, Miro JM, Garda-Samaniego J i sur. Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations. J Virol Hepat 2004; 11: 2-17.
24. BHIVA DRAFT GUIDELINES: Co-infection with HIV and Hepatitis C Virus Infection. U: http://www.aids-map.com/about/bhiva/DraftGDHepC.asp: February 2003; Accessed May 30, 2004.
25. Garcia-Samaniego J, Soriano V, Miro JM i sur. Management of chronic viral hepatitis in HIV-infected patients: Spanish Consensus Conference. October 2000. HIV Clin Trials 2002; 3:99-114.